SCHEMBL277768

SCHEMBL277768

CC(C)C(C)CNCC(C)C(C)C

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.32
ADH1C P00326 1/20 0.32
ADH1A P07327 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13995862 0.90 ANPEP (0.39) ADH1BADH1CADH1A
SCHEMBL13995756 0.90 ANPEP (0.39) ADH1BADH1CADH1A
SCHEMBL3159559 0.90 ANPEP (0.39) ADH1BADH1CADH1A
SCHEMBL31008668 0.86
SCHEMBL8692946 0.86
SCHEMBL23010583 0.85 ALDH1A1 (0.33)
SCHEMBL439571 0.83
SCHEMBL13995757 0.83 ALDH1A1 (0.31)
SCHEMBL20878685 0.83
SCHEMBL13995758 0.83 ALDH1A1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260115648-A1 Non-Triazine Based Scavengers CHAMPIONX LLC (US) 2026-04-30 US claimed
WO-2026090241-A1 NON-TRIAZINE BASED SCAVENGERS CHAMPIONX LLC (US) 2026-04-30 WO claimed
WO-2026090241-A1 NON-TRIAZINE BASED SCAVENGERS CHAMPIONX LLC (US) 2026-04-30 WO disclosed
US-20260115648-A1 Non-Triazine Based Scavengers CHAMPIONX LLC (US) 2026-04-30 US disclosed
US-11548984-B2 Light- or heat-curing method and curable resin composition FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2023-01-10 US disclosed
US-10774062-B2 Photocuring method, compound and composition used therein FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2020-09-15 US disclosed
EP-3409709-B1 PHOTOCURING METHOD, COMPOUND AND COMPOSITION USED THEREIN FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2020-08-19 EP disclosed
EP-3327002-B1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2020-08-19 EP disclosed
US-20200123324-A1 LIGHT- OR HEAT-CURING METHOD AND CURABLE RESIN COMPOSITION FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2020-04-23 US disclosed
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2019-10-08 US disclosed
US-10428015-B2 Acid-resistant base and/or radical generator, and curable resin composition containing said base and/or radical generator FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-10-01 US disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed
US-5763639-A REACTION OF AMINE WITH (DI)ALDEHYDE, HYDROCYANIC ACID OR ALKALI METAL CYANIDE, QUATERNIZATION WITH ALKYLATING AGENT BASF AKTIENGESELLSCHAFT (DE) 1998-06-09 US disclosed
EP-0562832-A1 Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use SANKYO COMPANY LIMITED (JP) 1993-09-29 EP disclosed
US-4468526-A Process for the preparation of thiuram disulfides AKZONA INCORPORATED (US) 1984-08-28 US disclosed
US-4459424-A SECONDARY AMINE, CARBON DISULFIDE, METAL CONTAINING CATALYST AKZONA INCORPORATED (US) 1984-07-10 US disclosed
US-4113764-A Manufacture of N-substituted glycinonitriles BASF AKTIENGESELLSCHAFT (DE) 1978-09-12 US disclosed
US-4022815-A Manufacture of substituted glycinonitriles BASF AKTIENGESELLSCHAFT (DT) 1977-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10428015-B2 Acid-resistant base and/or radical generator, and curable resin composition containing said base and/or radical generator REV1, RER1, CBR1 ADH1B 1483/4885ADH1C 1544/4885ADH1A 1243/4885
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, MRPS18A ADH1B 858/4885ADH1C 1107/4885ADH1A 535/4885
US-10774062-B2 Photocuring method, compound and composition used therein ESD, TMT1A, PAM ADH1B 266/4885ADH1C 744/4885ADH1A 609/4885
US-20260115648-A1 Non-Triazine Based Scavengers CBS, TST, GSS ADH1B 2381/4885ADH1C 265/4885ADH1A 723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.